{"entity":{"id":"immune-product-evidence","kind":"term","name":"Immune measurements and product evidence","aka":[],"tldr":"Each immune test or product-quality check answers a particular question. Connecting those questions helps explain how a proposed treatment moves from molecular measurements to evidence in people.","summary":"This reading map links immune-assay readouts, antigen evidence, specimen preparation, RNA design, recognition modules and product quality. It is a set of evidence questions, not a required experimental sequence. Receptor binding, cytokine release, cell killing, lot potency and clinical benefit are different observations. A useful explanation names the sample, assay, model and comparison that support the claim, including the steps that remain untested.","asOf":"2026-11-08","links":[{"label":"Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.","url":"https://doi.org/10.1186/1471-2172-9-9"},{"label":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.","url":"https://doi.org/10.1038/ncomms13404"},{"label":"FDA: Potency Assurance for Cellular and Gene Therapy Products, final guidance (November 2026)","url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-potency-assurance-cellular-and-gene-therapy-products"}],"tags":[],"related":["elispot","intracellular-cytokine-staining","peptide-hla-multimer-staining","immune-cytotoxicity-assays","tcr-repertoire-sequencing","tcr-repertoire-clonality","pbmc-specimens","binding-presentation-recognition","immunopeptidome","immunopeptidomics","peptide-hla-binding-prediction","immunodominance","epitope-spreading","self-similarity-immune-recognition","immunogenicity-versus-efficacy","tissue-preparation-assay-fit","finite-tissue-budget","rna-integrity","specimen-provenance","mrna-construct-anatomy","codon-optimization","modified-rna-nucleosides","in-vitro-transcription","dsrna-impurities","multi-epitope-constructs","binder-targeting-module","binder-affinity-epitope-developability","binder-format-constraints","scfv-vhh-formats","delivery-target-versus-therapeutic-target","chemistry-manufacturing-controls","certificate-of-analysis","manufacturing-process-comparability","cell-segmentation","targeted-proteomics-quantification"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Methods and models"},"route":"/terms/immune-product-evidence/","neighbours":{"term":[{"id":"binder-affinity-epitope-developability","kind":"term","name":"Binder affinity, epitope and developability","route":"/terms/binder-affinity-epitope-developability/"},{"id":"binder-targeting-module","kind":"term","name":"Binders as targeting modules","route":"/terms/binder-targeting-module/"},{"id":"cell-segmentation","kind":"term","name":"Cell segmentation in tissue measurements","route":"/terms/cell-segmentation/"},{"id":"certificate-of-analysis","kind":"term","name":"Certificate of analysis","route":"/terms/certificate-of-analysis/"},{"id":"chemistry-manufacturing-controls","kind":"term","name":"Chemistry, manufacturing and controls","route":"/terms/chemistry-manufacturing-controls/"},{"id":"codon-optimization","kind":"term","name":"Codon optimization","route":"/terms/codon-optimization/"},{"id":"manufacturing-process-comparability","kind":"term","name":"Comparability after manufacturing changes","route":"/terms/manufacturing-process-comparability/"},{"id":"delivery-target-versus-therapeutic-target","kind":"term","name":"Delivery targets and therapeutic targets","route":"/terms/delivery-target-versus-therapeutic-target/"},{"id":"dsrna-impurities","kind":"term","name":"Double-stranded RNA impurities","route":"/terms/dsrna-impurities/"},{"id":"elispot","kind":"term","name":"ELISpot secretion assays","route":"/terms/elispot/"},{"id":"epitope-spreading","kind":"term","name":"Epitope spreading","route":"/terms/epitope-spreading/"},{"id":"finite-tissue-budget","kind":"term","name":"Finite tissue and specimen allocation","route":"/terms/finite-tissue-budget/"},{"id":"binder-format-constraints","kind":"term","name":"Format-dependent binder function","route":"/terms/binder-format-constraints/"},{"id":"immune-cytotoxicity-assays","kind":"term","name":"Immune-cell cytotoxicity assays","route":"/terms/immune-cytotoxicity-assays/"},{"id":"immunodominance","kind":"term","name":"Immunodominance","route":"/terms/immunodominance/"},{"id":"immunogenicity-versus-efficacy","kind":"term","name":"Immunogenicity and clinical efficacy","route":"/terms/immunogenicity-versus-efficacy/"},{"id":"immunopeptidome","kind":"term","name":"Immunopeptidome","route":"/terms/immunopeptidome/"},{"id":"immunopeptidomics","kind":"term","name":"Immunopeptidomics","route":"/terms/immunopeptidomics/"},{"id":"in-vitro-transcription","kind":"term","name":"In vitro transcription for RNA products","route":"/terms/in-vitro-transcription/"},{"id":"intracellular-cytokine-staining","kind":"term","name":"Intracellular cytokine staining","route":"/terms/intracellular-cytokine-staining/"},{"id":"mrna-construct-anatomy","kind":"term","name":"Messenger RNA construct anatomy","route":"/terms/mrna-construct-anatomy/"},{"id":"modified-rna-nucleosides","kind":"term","name":"Modified nucleosides in messenger RNA","route":"/terms/modified-rna-nucleosides/"},{"id":"multi-epitope-constructs","kind":"term","name":"Multi-epitope constructs and antigen processing","route":"/terms/multi-epitope-constructs/"},{"id":"neoantigen","kind":"term","name":"Neoantigen","route":"/terms/neoantigen/"},{"id":"binding-presentation-recognition","kind":"term","name":"Peptide binding, presentation and immune recognition","route":"/terms/binding-presentation-recognition/"},{"id":"peptide-hla-binding-prediction","kind":"term","name":"Peptide-HLA binding and ligand prediction","route":"/terms/peptide-hla-binding-prediction/"},{"id":"peptide-hla-multimer-staining","kind":"term","name":"Peptide-HLA multimer staining","route":"/terms/peptide-hla-multimer-staining/"},{"id":"pbmc-specimens","kind":"term","name":"Peripheral blood mononuclear cell specimens","route":"/terms/pbmc-specimens/"},{"id":"rna-integrity","kind":"term","name":"RNA integrity and assay suitability","route":"/terms/rna-integrity/"},{"id":"self-similarity-immune-recognition","kind":"term","name":"Self-similarity and immune-recognition specificity","route":"/terms/self-similarity-immune-recognition/"},{"id":"scfv-vhh-formats","kind":"term","name":"Single-chain and single-domain antibody fragments","route":"/terms/scfv-vhh-formats/"},{"id":"specimen-provenance","kind":"term","name":"Specimen provenance and derivative tracking","route":"/terms/specimen-provenance/"},{"id":"tcr-repertoire-clonality","kind":"term","name":"T-cell receptor repertoire diversity and clonality","route":"/terms/tcr-repertoire-clonality/"},{"id":"tcr-repertoire-sequencing","kind":"term","name":"T-cell receptor repertoire sequencing","route":"/terms/tcr-repertoire-sequencing/"},{"id":"targeted-proteomics-quantification","kind":"term","name":"Targeted proteomics and quantification limits","route":"/terms/targeted-proteomics-quantification/"},{"id":"tissue-preparation-assay-fit","kind":"term","name":"Tissue preparation and assay suitability","route":"/terms/tissue-preparation-assay-fit/"}]}}